Hepatic KLF9 Intervention

Blocks DHEA Conversion

Knockdown of hepatic KLF9 suppresses intrahepatic androgen conversion, alleviating hyperandrogenism in PCOS and providing a novel liver-ovary axis-targeted entity.

Wang, Jing · Yan, Xiurui · Zhang, Yujie · Zhang, Yinliang · Ha, Chunfang · Hu, Rong · Chang, Yongsheng · Zhang, Yaolin · Fan, Heng

Advanced Science 2025

Advantages

Hepatocyte-specific Klf9 ablation significantly alleviates DHEA-induced PCOS progression

Hepatic Klf9 transgenic mice spontaneously exhibit PCOS-like phenotypes